Knocking down FBXO21 also promoted cell differentiation, indicated by increased expression of CD11b in MOLM-13 cells (Fig. 2F) and CD15 in primary AML cells and AML cell lines, both mature myeloid cell surface markers (Fig. 2G, and Supplementary Fig. 1D). Here, FBXO21 is linked to acute myeloid leukemia.